<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00527332</url>
  </required_header>
  <id_info>
    <org_study_id>EudraCT nr 2006-002520-41</org_study_id>
    <nct_id>NCT00527332</nct_id>
  </id_info>
  <brief_title>Effects of General Anesthesia and Spinal-Morphine Anesthesia on Recovery and Comfort After Benign Abdominal Hysterectomy</brief_title>
  <official_title>General Anesthesia Versus Spinal Anesthesia Combined With Intrathecal Morphine in Abdominal Hysterectomy for Benign Gynecological Diseases. A Randomized Open Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Preben Kjolhede</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether spinal anesthesia combined with intrathecal
      morphine in abdominal hysterectomy on benign gynecological indications gives better outcome
      concerning duration of hospital stay and postoperative patient comfort than general
      anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of Hospital Stay.</measure>
    <time_frame>Within 6 months after surgery</time_frame>
    <description>Duration of hospital stay defined as time from start anesthesia to leaving the hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence and Degree of Postoperative Symptoms.</measure>
    <time_frame>Within 6 months after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Consumption of Analgesics and Antiemetics.</measure>
    <time_frame>Within 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications and Complication Rates.</measure>
    <time_frame>Within 6 months after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life and QALYs (Quality Adjusted Life Years).</measure>
    <time_frame>Within 6 months after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sick Leave.</measure>
    <time_frame>Within 6 months after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Stress Coping Ability Impact on Postoperative Symptoms and Recovery.</measure>
    <time_frame>Within 6 months after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Economy.</measure>
    <time_frame>Within 6 months after the surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Hysterectomy (MeSH nr: E04.950.300.399)</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spinal anesthesia combined with intrathecal morphine. Spinal anesthesia applied in intervertebral space L3/L4 or L2/L3 with hyperbaric bupivacaine 20 mg and morphine 0.2 mg intrathecally. Sedation with propofol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>General anesthesia. General anesthesia induced with propofol, fentanyl and rocuronium, and maintained with propofol and oxygen in air. Rocuronium and fentanyl repeated when needed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacain</intervention_name>
    <description>5 mg/mL, 4 mL intrathecally as a single dos</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Marcain spinal tung.</other_name>
    <other_name>ATC-code: N01BB01</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>0.4 mg/mL; 0.5 mL intrathecally as a single dosage</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Morfin Special</other_name>
    <other_name>ATC-code: N02AA01</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>2-5 mg/kg body weight/hours IV (intravenously) for sedation during the surgery</description>
    <arm_group_label>A</arm_group_label>
    <other_name>ATC-code: N01AX10</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Induction of anesthesia with 1-2 mg/kg body weight IV (intravenously). After intubation maintenance dosage of 6-10 mg/kg/hour IV during the surgery</description>
    <arm_group_label>B</arm_group_label>
    <other_name>ATC-code: N01AX10</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>100-200 microgram IV (intravenously) at start of anesthesia. 50-100 microgram IV on demand during surgery.</description>
    <arm_group_label>B</arm_group_label>
    <other_name>ATC-code:N01AH01</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronbromid</intervention_name>
    <description>0.6 mg/kg body weight IV (intravenously) at induction of anesthesia. If additional muscle relaxation is needed during surgery 5-10 mg is injected IV. The drug is given only at induction of anesthesia and during surgery</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Esmeron</other_name>
    <other_name>ATC-code: M03AC09</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>5 mg is given IV (intravenously) before end of surgery</description>
    <arm_group_label>B</arm_group_label>
    <other_name>ATC-code: N02AA01</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female between 18 and 60 years of age.

          -  Scheduled for abdominal hysterectomy - total or subtotal -on benign gynecological
             indication.

          -  At least one ovary planned to be preserved at the hysterectomy.

          -  Can understand and communicate in Swedish

          -  Accept participation after written and verbal information and after signed informed
             consent.

          -  Has supervision at home after discharge from hospital during the first couple of days
             and has access to a telephone.

        Exclusion Criteria:

          -  Contra-indications against spinal or general anesthesia or the standard dosage of the
             study drugs

          -  ASA classification ≥ Class 3

          -  Postmenopausal women without HRT (hormone replacement therapy).

          -  Suspected gynecological malignancy

          -  Previously undergone bilateral oophorectomy

          -  Substantial physically disabled so that a normal recovery with early physical
             mobilization can not be anticipated.

          -  Mentally or severly psychic disabled
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Preben Kjölhede, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, University Hospital, Linköping</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lena Nilsson, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anesthesiology, University Hospital, Linköping</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ninnie B. Wodlin, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Obstetrics and Gynecology, University Hospital, Linköping</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth Krohn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ostetrics and Gynecology, Vrinnevi Hospital, Norrköping</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lars Nordenberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Vrinnevi Hospital, Norrköping</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mats D. Karlsson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology, Ryhov Hospital, Jönköping</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Veronica Annerhagen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Ryhov Hospital, Jönköping</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christina Gunnervik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology, Värnamo Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Magnus Trofast, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Värnamo Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tomasz Stypa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology, Eksjö Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Albert Sundberg, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Eksjö Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eksjö Hospital</name>
      <address>
        <city>Eksjö</city>
        <zip>57581</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ryhov Hospital</name>
      <address>
        <city>Jönköping</city>
        <zip>55185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Linköping</city>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vrinnevi Hospital</name>
      <address>
        <city>Norrköping</city>
        <zip>60182</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Värnamo Hospital</name>
      <address>
        <city>Värnamo</city>
        <zip>33185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Vårdtid, funktionskapacitet och sjukskrivningstider efter hysterektomi. Nationella data från 6503 patienter opererade år 2000 och 2001. Återrapport från Nationella registret för kvalitetsutveckling inom gynekologisk kirurgi (Gynop-registret), SFOG, 2003.</citation>
  </reference>
  <reference>
    <citation>Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002 Jun;183(6):630-41. Review.</citation>
    <PMID>12095591</PMID>
  </reference>
  <reference>
    <citation>Wilmore DW, Kehlet H. Management of patients in fast track surgery. BMJ. 2001 Feb 24;322(7284):473-6. Review.</citation>
    <PMID>11222424</PMID>
  </reference>
  <reference>
    <citation>Møller C, Kehlet H, Friland SG, Schouenborg LO, Lund C, Ottesen B. Fast track hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2001 Sep;98(1):18-22.</citation>
    <PMID>11516794</PMID>
  </reference>
  <reference>
    <citation>Persson P, Wijma K, Hammar M, Kjølhede P. Psychological wellbeing after laparoscopic and abdominal hysterectomy--a randomised controlled multicentre study. BJOG. 2006 Sep;113(9):1023-30.</citation>
    <PMID>16956334</PMID>
  </reference>
  <reference>
    <citation>Ellström MA, Aström M, Möller A, Olsson JH, Hahlin M. A randomized trial comparing changes in psychological well-being and sexuality after laparoscopic and abdominal hysterectomy. Acta Obstet Gynecol Scand. 2003 Sep;82(9):871-5.</citation>
    <PMID>12911451</PMID>
  </reference>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2007</study_first_submitted>
  <study_first_submitted_qc>September 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2007</study_first_posted>
  <results_first_submitted>November 14, 2011</results_first_submitted>
  <results_first_submitted_qc>November 14, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 21, 2011</results_first_posted>
  <last_update_submitted>January 24, 2012</last_update_submitted>
  <last_update_submitted_qc>January 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Preben Kjolhede</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Hospitalization</keyword>
  <keyword>Postoperative care</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Health economy</keyword>
  <keyword>Anesthesia. Spinal</keyword>
  <keyword>Anesthesia, General</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Spinal Anesthesia</title>
          <description>Spinal anesthesia combined with intrathecal morphine</description>
        </group>
        <group group_id="P2">
          <title>General Anesthesia</title>
          <description>General anesthesia</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="91"/>
                <participants group_id="P2" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="82"/>
                <participants group_id="P2" count="80"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrew consent</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Spinal Anesthesia</title>
          <description>Spinal anesthesia combined with intrathecal morphine</description>
        </group>
        <group group_id="B2">
          <title>General Anesthesia</title>
          <description>General anesthesia</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="91"/>
            <count group_id="B2" value="89"/>
            <count group_id="B3" value="180"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.9" spread="5.5"/>
                    <measurement group_id="B2" value="46.0" spread="6.0"/>
                    <measurement group_id="B3" value="45.9" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Duration of Hospital Stay.</title>
        <description>Duration of hospital stay defined as time from start anesthesia to leaving the hospital</description>
        <time_frame>Within 6 months after surgery</time_frame>
        <population>Participants who completed the study were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Spinal Anesthesia</title>
            <description>Spinal anesthesia combined with intrathecal morphine. Spinal anesthesia applied in intervertebral space L3/L4 or L2/L3 with hyperbaric bupivacaine 20 mg and morphine 0.2 mg intrathecally. Sedation with propofol.</description>
          </group>
          <group group_id="O2">
            <title>General Anesthesia</title>
            <description>General anesthesia. General anesthesia induced with propofol, fentanyl and rocuronium, and maintained with propofol and oxygen in air. Rocuronium and fentanyl repeated when needed.</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Hospital Stay.</title>
          <description>Duration of hospital stay defined as time from start anesthesia to leaving the hospital</description>
          <population>Participants who completed the study were analyzed</population>
          <units>Hours</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46" lower_limit="22" upper_limit="125"/>
                    <measurement group_id="O2" value="50" lower_limit="24" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Occurrence and Degree of Postoperative Symptoms.</title>
        <time_frame>Within 6 months after the surgery</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Consumption of Analgesics and Antiemetics.</title>
        <time_frame>Within 6 months after surgery</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Complications and Complication Rates.</title>
        <time_frame>Within 6 months after the surgery</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life and QALYs (Quality Adjusted Life Years).</title>
        <time_frame>Within 6 months after the surgery</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sick Leave.</title>
        <time_frame>Within 6 months after the surgery</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Stress Coping Ability Impact on Postoperative Symptoms and Recovery.</title>
        <time_frame>Within 6 months after the surgery</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health-related Economy.</title>
        <time_frame>Within 6 months after the surgery</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Spinal Anesthesia</title>
          <description>Spinal anesthesia combined with intrathecal morphine</description>
        </group>
        <group group_id="E2">
          <title>General Anesthesia</title>
          <description>General anesthesia</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infections</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="91"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Urinary bladder injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="91"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal wound complication</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="91"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Lower urinary tract infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="91"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Preben Kjolhede</name_or_title>
      <organization>Deptartment of Obstetrics and Gynecology, University Hospital, Linköping, Sweden</organization>
      <phone>+46101030000 ext 3187</phone>
      <email>Preben.Kjolhede@lio.se</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

